<DOC>
	<DOCNO>NCT00125203</DOCNO>
	<brief_summary>The purpose study determine safety efficacy Myobloc ALS patient excessive drooling . The primary goal study determine patient perceives benefit Myobloc control excessive drooling .</brief_summary>
	<brief_title>Study Myobloc Treatment Sialorrhea ( Drooling ) Patients With Amyotrophic Lateral Sclerosis ( ALS )</brief_title>
	<detailed_description>The secondary goal study : - determine safety bilateral injection Myobloc parotid submandibular gland effort control sialorrhea ; - determine objective measure Myobloc injection decrease saliva produce ; - determine caregiver perceive benefit Myobloc injection .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Motor Neuron Disease</mesh_term>
	<mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
	<mesh_term>Sialorrhea</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<mesh_term>rimabotulinumtoxinB</mesh_term>
	<criteria>Diagnosis probable definite ALS base current World Federation Neurology criterion Between age 2185 , inclusive Sialorrhea refractory treatment least two anticholinergic medication OR intolerant anticholinergic medication due side effect Capable give informed consent Must able attend study visit Patient uncontrolled significant medical , psychiatric neurological disease ( ALS ) past 30 day History ongoing substance abuse History noncompliance treatment experimental protocol Can provide informed consent comply evaluation procedure Has receive form botulinum toxin past indication Women pregnant , lactating , child bear potential use adequate form birth control Currently treat coumadin Forced vital capacity ( FVC ) &lt; 40 % predict unless tidal volume &gt; 600cc , patient significant bulbar weakness may show falsely low FVC due bulbar muscle spasticity</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>ALS</keyword>
	<keyword>Lou Gehrig 's Disease</keyword>
	<keyword>Motor Neuron Disease</keyword>
	<keyword>Amyotrophic Lateral Sclerosis</keyword>
	<keyword>Sialorrhea</keyword>
	<keyword>Hypersalivation</keyword>
	<keyword>Excessive Drooling</keyword>
	<keyword>Myobloc</keyword>
	<keyword>botulinum toxin type B</keyword>
	<keyword>Clostridium botulinum B toxin</keyword>
	<keyword>botulinum B toxin</keyword>
	<keyword>botulinum neurotoxin B</keyword>
	<keyword>NeuroBloc</keyword>
</DOC>